Brokerages Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) Target Price at $98.75

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have been given an average rating of “Moderate Buy” by the thirteen analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, nine have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $98.75.

GEHC has been the subject of several research reports. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their price objective for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Finally, Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th.

Institutional Investors Weigh In On GE HealthCare Technologies

Institutional investors have recently modified their holdings of the business. OneDigital Investment Advisors LLC grew its holdings in GE HealthCare Technologies by 7.5% in the third quarter. OneDigital Investment Advisors LLC now owns 13,798 shares of the company’s stock valued at $1,295,000 after purchasing an additional 961 shares during the period. Empowered Funds LLC grew its position in shares of GE HealthCare Technologies by 30.7% in the third quarter. Empowered Funds LLC now owns 23,470 shares of the company’s stock valued at $2,203,000 after purchasing an additional 5,512 shares during the period. Mutual of America Capital Management LLC increased its stake in shares of GE HealthCare Technologies by 5.0% during the third quarter. Mutual of America Capital Management LLC now owns 56,349 shares of the company’s stock worth $5,288,000 after purchasing an additional 2,696 shares in the last quarter. Thrivent Financial for Lutherans raised its position in shares of GE HealthCare Technologies by 16.5% during the 3rd quarter. Thrivent Financial for Lutherans now owns 25,408 shares of the company’s stock worth $2,385,000 after purchasing an additional 3,602 shares during the last quarter. Finally, Swiss National Bank lifted its stake in GE HealthCare Technologies by 0.5% in the 3rd quarter. Swiss National Bank now owns 1,287,187 shares of the company’s stock valued at $120,802,000 after buying an additional 6,500 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Up 0.9 %

Shares of GEHC stock opened at $82.46 on Wednesday. The stock’s fifty day moving average price is $86.91 and its 200 day moving average price is $85.96. GE HealthCare Technologies has a 1-year low of $74.51 and a 1-year high of $94.80. The company has a market cap of $37.71 billion, a price-to-earnings ratio of 19.04, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, research analysts expect that GE HealthCare Technologies will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.